Salvage Chemotherapy and Recurrent Ovarian Cancer

Links shared publicly online about this topic

Bevacizumab Added to Chemotherapy Provides Meaningful Benefit in Recurrent Ovarian Cancer

onclive.com — “Women with recurrent platinum-sensitive ovarian cancer had a 50% improvement in PFS when bevacizumab was added to chemotherapy and continued as maintenance therapy.View full resource at onclive.com

  • View Related
  • Share

Most Recently Shared on July 27, 2011 at 7:45 pm By:

ONClive Editor Oncology

Bevacizumab Added to Chemotherapy Provides Meaningful Benefit in Recurrent Ovarian Cancer http://t.co/gLOIrDB

10 months ago...

ChemoFx-assisted chemotherapy reduces treatment costs for recurrent ovarian cancer

news-medical.net — “A study demonstrating the cost savings realized through the use of the ChemoFx® Drug Response Marker for assisting selection of treatment in recurrent ovarian cancer was published recently in the American Journal of Obstetrics and Gynecology (AJOG).View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 4, 2010 at 9:26 am By:

NewsMedical News-Medical.Net Health News

ChemoFx-assisted chemotherapy reduces treatment costs for recurrent ovarian cancer: A study demonstrating the cost... http://bit.ly/bn3YeK

2 years ago...

Ovarian Cancer: Gynecologist Disputes Findings

medicalnewstoday.com — “An internationally-recognized gynecologic oncologist at St. Joseph's Hospital and Medical Center in Phoenix, Arizona is warning that the results from a long-awaited global study of ovarian cancerView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 18, 2010 at 1:05 pm By:

Oncology Medical News about Ovarian Neoplasms Antineoplastic Combined Chemotherapy Protocols

mdlinx.com — “Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 18, 2010 at 10:20 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer... http://bit.ly/dBkn2n #oncology

2 years ago...

Ovarian Cancer: eMedicine Oncology

emedicine.medscape.com — “Overview: Ovarian cancer is the most common cause of cancer death from gynecologic tumors in the United States. Early disease causes minimal, nonspecific, or no symptoms. Therefore, most cases are diagnosed in an advanced stage. Overall, prognosis ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on April 12, 2010 at 6:04 pm By:

MedscapeOnc Medscape Oncology Oncology and Health Site

Ovarian Cancer: Study finds cytoreductive surgery safe and effective in platinum-sensitive recurrent ovarian cancer. http://bit.ly/9ZmUBA

2 years ago...

Medical News: ASCO: Targeted Agent Slows Recurrent Ovarian Cancer - in Meeting Coverage, ASCO from MedPage Today

medpagetoday.com — “CHICAGO -- Women with recurrent platinum-sensitive ovarian cancer had a 50% improvement in progression-free survival when bevacizumab (Avastin) was added to chemotherapy, results of a multicenter randView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on June 8, 2011 at 10:08 pm By:

MedicalNews Medical News Health News

ASCO: Targeted Agent Slows Recurrent Ovarian Cancer (with video) http://bit.ly/m03Klj

12 months ago...

Medical News: ASCO: Targeted Agent Slows Recurrent Ovarian Cancer - in Meeting Coverage, ASCO from MedPage Today

medpagetoday.com — “CHICAGO -- Women with recurrent platinum-sensitive ovarian cancer had a 50% improvement in progression-free survival when bevacizumab (Avastin) was added to chemotherapy, results of a multicenter randView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 29, 2011 at 7:24 pm By:

Medical News: SGO: Drug Combination Slows Recurrent Ovarian Cancer - in Meeting Coverage, SGO from MedPage Today

medpagetoday.com — “SAN FRANCISCO -- Combination chemotherapy resulted in a longer, progression-free survival (PFS) than did sequential therapy in a randomized clinical trial of patients with recurrent, platinum-sensitivView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 15, 2010 at 2:41 pm By:

medical_tweets medical_tweets Health News

SGO: Drug Combination Slows Recurrent Ovarian Cancer (CME/CE) SAN FRANCISCO (MedPage Today) -- Combination chemothera.. http://bit.ly/bNbtkZ

2 years ago...

Genentech Announces Data To Show Avastin-Based Regimen Halved The Risk Of Disease Getting Worse In Women With Recurrent Ovarian Cancer

medicalnewstoday.com — “Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from OCEANS, a Phase III study evaluating Avastin® (bevacizumab) in combination with chemotherapy (View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 6, 2011 at 10:05 am By:

mnt_womenhealth MNT Women's Health Health News

Genentech Announces Data To Show Avastin-Based Regimen Halved The Risk Of Disease Getting Worse In Women With Recurren... http://mnt.to/3WNk

12 months ago...

Genentech Announces Data To Show Avastin-Based Regimen Halved The Risk Of Disease Getting Worse In Women With Recurrent Ovarian Cancer

medicalnewstoday.com — “Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from OCEANS, a Phase III study evaluating Avastin® (bevacizumab) in combination with chemotherapy (View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 6, 2011 at 1:16 pm By:

vervilledeb1 Debby Verville Health Advocate

Genentech Announces Data To Show Avastin-Based Regimen Halved The Risk Of Disease Getting Worse In Women With Re... http://bit.ly/m03fYD

12 months ago...

Oncology Medical News about ovarian cancer

mdlinx.com — “A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on January 13, 2010 at 10:11 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Heme/Onc: A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer: Cancer Chemotherapy and Pharmacol http://url4.eu/17I5Z

2 years ago...

Ob/Gyn Medical News about Ovarian Neoplasms Antineoplastic Combined Chemotherapy Protocols

mdlinx.com — “Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 18, 2010 at 2:26 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer: Coc... http://bit.ly/dcVk1E #OBG

2 years ago...

Oncology Article | Ovarian Neoplasms

mdlinx.com — “Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent diseaseView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on April 12, 2011 at 10:31 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and r... http://bit.ly/hH6IxF #oncology

1 year ago...

Medical News: No Benefit for Early Tx of Ovarian Cancer Relapse - in Oncology/Hematology, Ovarian Cancer from MedPage Today

medpagetoday.com — “Women who get early chemotherapy for a recurrence of ovarian cancer won't live longer, researchers say.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on October 1, 2010 at 1:50 pm By:

FightCancer FightCancer Health News

No Benefit for Early Tx of Ovarian Cancer Relapse (CME/CE) http://bit.ly/cqrGfz

2 years ago...

New treatment shows promise against recurrent gynecologic cancers

physorg.com — “(BRONX, NY) - Recurrent and metastatic endometrial and ovarian cancers can be notoriously difficult to treat: They have spread to other organs and typically have developed resistance to chemotherapy; and patients already heavily treated with chemotherapy may not be able to endure more chemo. Now, physicians ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on April 21, 2009 at 11:55 pm By:

FightCancer FightCancer Health News

New treatment shows promise against recurrent gynecologic cancers http://tinyurl.com/cgnpe9

3 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390